Compass Pathways PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Compass Pathways Plc - ADR: Is Infosys Ltd. worth buying?
Item: Compass Pathways Plc - ADR
Rating: 1.92108325
Author: Trendlyne DVM scores

about

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The ...

12.53 0.59 (4.94%)

456.89% Gain from 52W Low

3.6M

XNAS Volume

XNAS 18 Jun, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

4.8 / 100

Technically Bullish

72.0 / 100

No estimates available

Compass Pathways PLC (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Compass Pathways PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The ...

456.89% Gain from 52W Low

SWOT Analysis

Compass Pathways PLC (ADR) Live Price Chart